Corcept Therapeutics IncorporatedShare Price
|
|
Share Price & Volume
| Previous Close | $51.20 | |
| Open | -0.10% | $51.15 |
| Day Low | -1.17% | $50.60 |
| Day High | +0.55% | $51.48 |
| 52-Week Low | -44.02% | $28.66 |
| 52-Week High | +77.73% | $91.00 |
| Day Volume | 623,727 | |
| Average Volume | 1,693,346 | |
| EPS (TTM) | $0.35 | |
| P/E (TTM) | 146.17x | |
| FWD P/E (NTM) | 65.79x | |
| Next Earnings Date | Jul 30, 2026 |
| Market Cap | 5,492,128,320 | |
| Shares Outstanding (Millions) | 107,352,000 | |
| Dividend | - | |
| Beta | 0.36 | |
| ROE | 0.07% | |
| ROA | -0.01% |
Analyst Ratings and Price Targets
Current:
$51.16
Average:
$76.67
(+49.86%)
Low:
$60.00
(+17.28%)
High:
$110.00
(+115.01%)
You need to login to see this data
| HC Wainwright & Co. | Maintains | Buy | $75.00 | +46.60% | May 3, 2026 |
| Piper Sandler | Maintains | Overweight | $88.00 | +72.01% | Apr 30, 2026 |
| Canaccord Genuity | Maintains | Buy | $110.00 | +115.01% | Mar 25, 2026 |
Headquarters
Menlo Park, CA, USA
Sector
Industry
# of Employees
500